ELIGARD is a prescription drug, given by injection, for the management of advanced prostate cancer. However, there is no known cure for advanced prostate cancer. ELIGARD is a type of hormonal therapy called “luteinizing hormone-releasing hormone” (LHRH) agonist. These types of drugs lower male hormone levels. Specifically, they lower levels of the hormone testosterone.
Testosterone “stimulates” cancer cells
Most of the body’s testosterone is made by the testicles. Testosterone stimulates the growth of prostate cancer cells.
ELIGARD targets a source of production
ELIGARD suppresses testosterone produced by the testicles. This may help slow the growth of prostate cancer.
A temporary rise in testosterone levels is common
Like all similar drugs, the first injection of ELIGARD makes testosterone levels rise for a short period of time. This rise is called a “flare.”
This may cause a worsening of symptoms or new symptoms during the first few weeks of treatment.
Testosterone reaches suppression level in 3-4 weeks
Testosterone should reach suppression level in 3-4 weeks. Your doctor will monitor you to see if the product is working.
ELIGARD dissolves slowly and consistently over time under your skin.
ELIGARD uses a special delivery system called the ATRIGEL® Delivery System to ensure the controlled release of medicine over time.
NOTE: You may feel a tiny bump after injection. This will eventually go away (dissolve).
ELIGARD is the only drug of its kind administered under the skin (subcutaneously)
Drugs can be injected either directly into a vein, into muscle (intramuscular), or under the skin (subcutaneous) like ELIGARD. There are many sites on your body where your doctor can administer under your skin. He/she can rotate to different sites with each ELIGARD injection.
Discomfort associated with ELIGARD injections is temporary
The most common side effects related to the injection site are
- Burning and stinging
These side effects generally last a short period of time.